Health Condition 1: null- Pheochromocytoma
Conditions
Interventions
Control Intervention1: Phenoxybenzamine (an alpha blocker): Dose-
10 mg to 80 mg PO per day for 10-15 days depending on effect of alpha blockade
Control Intervention2: Prazosin (an alpha blocker): Dos
Sponsors
Sanjay Gandhi Post Graduate Institute of Medical Sciences
Eligibility
Inclusion criteria
Inclusion criteria: All patients with biochemically proven Pheochromocytoma/functional paraganglioma that will undergo surgery for removal of tumor
Exclusion criteria
Exclusion criteria: Those patients of pheochromocytoma who will not undergo surgery due to any reasons
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Assessment of strength and weaknesses of both drugs in terms of- 1. Preoperative time taken for adequate preparation and safety profile 2. Number of intra-operative and post-operative fluctuations in blood pressure and heart rate 3. Occurrence of arrythmia- pre-, intra- or postoperatively 4. Time taken for restoration of normal haemodynamics in post-operative periodTimepoint: End point of study 1. Till restoration of normal haemodynamics in post-operative period | — |
Secondary
| Measure | Time frame |
|---|---|
| NILTimepoint: Not Applicable | — |
Countries
India
Contacts
Public ContactProf SK Mishra
Department of Endocrine Surgery
Outcome results
None listed